Vaccination Program

'IAP Immunization Timetable 2014'
I. IAP recommended vaccines for routine use
Age
(completed weeks/months/years)
Vaccines Comments/Notes
 Birth -BCG
-OPV 0
-Hep-B 1
Administer these vaccines to all newborns before hospital Discharge  
 6 weeks -DTwP 1
-IPV 1
-Hep-B 2
-Hib 1
-Rotavirus 1
-PCV 1
DTP:
• DTaP vaccine/combinations should preferably be avoided for the primary series
• DTaP vaccine/combinations should be preferred in certain specific circumstances/conditions only
• No need of repeating/giving additional doses of whole- cell pertussis (wP) vaccine to a child who has earlier completed their primary schedule with acellular pertussis (aP) vaccine-containing products Polio: • All doses of IPV may be replaced with OPV if administration of the former is unfeasible

Polio:
• All doses of IPV may be replaced with OPV if administration of the former is unfeasible
• Additional doses of OPV on all supplementary immunization activities (SIAs)
• Two doses of IPV instead of 3 for primary series if started at 8 weeks, and 8 weeks interval between the doses
• No child should leave the facility without polio immunization (IPV or OPV), if indicated by the schedule

Rotavirus:
• 2 doses of RV1 and 3 doses of RV5
• RV1 should be employed in 10 & 14 week schedule,  instead of 6 & 10 week
• 10 & 14 week schedule of RV1 is found to be far more immunogenic than existing 6 & 10 week schedule
 10 weeks -DTwP 2
-IPV 2
-Hib 2
*Rotavirus 2
-PCV2
Rotavirus:
If RV1 is chosen, the first dose should be given at 10 weeks  
 14 weeks -DTwP 3
-IPV 3
-Hib 3
*Rotavirus 3
-PCV 3
Rotavirus:
• Only 2 doses of RV1 are recommended at present.
• If RV1 is chosen, the 2nd dose should be given at 14 Weeks
 6 Months  -OPV 1
-Hep-B 3
Hepatitis-B: 
The final (third or fourth) dose in the HepB vaccine series should be administered no earlier than age 24 weeks and at least 16 weeks after the first dose. 
 9 Months  -OPV 2
-MMR-1
MMR:
• Measles-containing vaccine ideally should not be administered before completing 270 days or 9 months of life;
• The 2nd dose must follow in 2nd  year of life; • No need to give stand-alone measles vaccine
 9  to 12 Months -Typhoid  Conjugate Vaccine • Currently, two typhoid conjugate vaccines, Typbar-TCV® and PedaTyph® available in Indian market;
• PedaTyph® is not yet approved; the recommendation is applicable to Typbar-TCV® only
• An interval of at least 4 weeks with the MMR vaccine should be maintained while administering this vaccine
• Should follow a booster at 2 years of age
 12 Months -Hep-A 1 Hepatitis A:
• Single dose for live attenuated H2-strain Hep-A vaccine
• Two doses for all killed Hep-A vaccines are recommended now
 15 Months -MMR 2
-Varicella 1
-PCV booster
MMR:
• The 2nd dose must follow in 2nd year of life
• However, it can be given at anytime 4-8 weeks after the 1st  dose Varicella: The risk of breakthrough varicella is lower if given 15 months onward
 6 to 18 Months -DTwP B1/DTaP B1 -IPV B1
-Hib B1
The first booster (4th dose) may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose.
DTP:
• First & second boosters should preferably be of DTwP
• Considering a higher reactogenicity of DTwP, DTaP can be considered for the boosters
 18 Months Hep-A 2 Hepatitis A: 2nd dose for killed vaccines; only single dose for live attenuated H2-strain vaccine 
 2 Years Typhoid booster • Either Typbar-TCV® or Vi-polysaccharide (Vi-PS) can be employed as booster;
• Typhoid revaccination every 3 years, if Vi-polysaccharide vaccine is used
• Need of revaccination following a booster of Typbar- TCV® not yet determined
 4 to 6 Years -DTwP B2/DTaP B2 -OPV 3
-Varicella 2
-Typhoid booster
Varicella: the 2nd dose can be given at anytime 3 months after the 1st dose.  
 10 to 12 Years -Tdap/Td
-HPV
Tdap: is preferred to Td followed by Td every 10 years.
HPV:
• Only 2 doses of either of the two HPV vaccines for adolescent / preadolescent girls aged 9-14 years;
• For girls 15 years and older, and immunocompromised individuals 3 doses are recommended
• For two-dose schedule, the minimum interval between doses should be 6 months.
• For 3 dose schedule, the doses can be administered at 0, 1-2 (depending on brands) and 6 months

II.IAP recommended vaccines for High-risk* children(Vaccines under special circumstances)

  • 1-Influenza Vaccine
  • 2-Meningococcal Vaccine
  • 3-JapaneseEncephalitis Vaccine
  • 4-Cholera Vaccine
  • 5-Rabies Vaccine
  • 6-YellowFever Vaccine
  • 7-PneumococcalPolysaccharide vaccine (PPSV 23)

*High-risk category of children:

  • » Congenital or acquired immunodeficiency (including HIVinfection),
  • » Chronic cardiac, pulmonary (including asthma if treated with prolonged high-dose oral corticosteroids), hematologic, renal (including nephrotic syndrome), and liver disease; 
  • » Children on long term steroids, salicylates, immunosuppressive or radiation therapy
  • » Diabetes mellitus, Cerebrospinal fluid leak, Cochlear implant, Malignancies,
  • » Children with functional/ anatomic asplenia/ hyposplenia
  • » During disease outbreaks
  • » Laboratory personnel and healthcare workers
  • » Travelers
  • » Children having pets in home
  • » Children perceived with higher threat of being bitten by dogs such as hostelers, risk of stray dog menace while going outdoor.